Eva Winning Lehmann, Signe Srensen Torekov, Glucagon-like peptide-1 receptor agonists: the key to healthy weight loss maintenance?, Cardiovascular Research, Volume 117, Issue 10, 1 September 2021, Pages e120e122, Jensen SBK, Blond MB, Sandsdal RM, Olsen LM, Juhl CR, Lundgren JR, Janus C, Stallknecht BM, Holst JJ, Madsbad S, Torekov SS
The story of GLP-1 starts with a simple question: Why do we feel full when we eat
Long-term safety data is still limited, so its essential to use it responsibly and consult with a healthcare professional
Additionally, while Tirzepatide is highly effective in facilitating substantial weight loss it will be most effective when it is used as one component of a broader medical weight management plan
Since these medications are still fairly new, we dont know all the possible long-term effects or risks